The pros and cons of beta-blockers in sepsis: Where do we stand in 2024?

The pros and cons of beta-blockers in sepsis: Where do we stand in 2024?

Saved in:

Bibliographic Details
Main Authors:	Daniel De Backer, Dechang Chen
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Journal of Intensive Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667100X24000781
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physician-assisted suicide in Italy: where do we stand and where do we want to go?
by: Emanuela Turillazzi, et al.
Published: (2025-07-01)

Mesenchymal stem/stromal cells as a therapeutic for sepsis: a review on where do we stand?
by: Courtney Premer, et al.
Published: (2025-05-01)

Cost of AF Ablation: Where Do We Stand?
by: Yaariv Khaykin, et al.
Published: (2011-01-01)

Probiotics in atopic dermatitis: Where do we stand?
by: Rashmi Agarwal, et al.
Published: (2023-01-01)

Brain Plasticity and the Labbé Procedure: Where do we stand?
by: Zhen Yu Wong, et al.
Published: (2025-06-01)

Venous ulcers of the lower limb: Where do we stand?
by: Chatterjee Sasanka S.
Published: (2012-05-01)

Difficulties in proving medical errors: Where do we stand?
by: Ignjatović-Ristić Dragana, et al.
Published: (2014-01-01)

Extracorporeal Cardiopulmonary Resuscitation—Where Do We Currently Stand?
by: Brandon E. Ferrell, et al.
Published: (2025-01-01)

Advanced Practice Nursing in Portugal – Where do we stand?
by: Patrícia Fonseca Nunes, et al.
Published: (2024-11-01)

The Research Agenda of Spiritual Leadership. Where Do We Stand?
by: Mariana NICOLAE, et al.
Published: (2013-10-01)

Modulators of corneal wound healing – Where do we stand?
by: Murugesan Vanathi
Published: (2024-12-01)

Lie groups and continuum mechanics: where do we stand today?
by: de Saxcé, Géry, et al.
Published: (2024-05-01)

Where we stand on doxyPEP depends on where we sit: a viewpoint
by: Thibaut Vanbaelen, et al.
Published: (2025-06-01)

Ovarian cancer prevention and screening – where do we stand today?
by: Cristina Bucur, et al.
Published: (2024-04-01)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
by: Gianluigi Savarese
Published: (2019-12-01)

Tertiary Review on Explainable Artificial Intelligence: Where Do We Stand?
by: Frank van Mourik, et al.
Published: (2024-08-01)

Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
by: Antje D Ebert, et al.
Published: (2015-07-01)

The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?
by: Fábio Ramos Costa, et al.
Published: (2025-03-01)

Early and Late Infections in Newborns: Where Do We Stand? A Review
by: Francesca Cortese, et al.
Published: (2016-08-01)

Women in Science: Where We Stand?—The WHEN Protocol
by: Francesca Arnaboldi, et al.
Published: (2025-03-01)

Enhanced External Counterpulsation in Chronic Heart Failure: Where Do We Stand?
by: Ryan Ranitya
Published: (2015-12-01)

Enhanced External Counterpulsation in Chronic Heart Failure: Where Do We Stand?
by: Ryan Ranitya
Published: (2015-12-01)

Enhanced External Counterpulsation in Chronic Heart Failure: Where Do We Stand?
by: Ryan Ranitya
Published: (2015-12-01)

Intra-tumoral susceptibility signals in brain gliomas: where do we stand?
by: Simone Cataldi, et al.
Published: (2025-02-01)

Computational advancements to facilitate therapeutic application of phytochemicals: Where do we stand?
by: Soumyadip Ghosh, et al.
Published: (2025-05-01)

Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
by: Suneet Mittal, et al.
Published: (2021-10-01)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
by: Antonella Sciarra, et al.
Published: (2021-09-01)

Computational pathology for breast cancer: Where do we stand for prognostic applications?
by: Grégoire Gessain, et al.
Published: (2025-06-01)

Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today?
by: Michiel Costers, et al.
Published: (2008-01-01)

CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
by: Pilar Lloret-Madrid, et al.
Published: (2025-05-01)

Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025?
by: Adriana Liliana Vlad, et al.
Published: (2025-05-01)

Patient-reported Outcomes in Foot and Ankle Practice: Where do We Stand in 2022?
by: Hadley A Leatherman, et al.
Published: (2023-10-01)

Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review
by: Fulvio Borella, et al.
Published: (2025-02-01)

Forensic Diatom Analysis: Where Do We Stand and What Are the Latest Diagnostic Advances?
by: Stefano Tambuzzi, et al.
Published: (2024-10-01)

Advancing quality of life research in chronic myeloid leukemia: where do we stand?
by: Jeffrey H. Lipton
Published: (2025-07-01)

Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
by: Alexander Siebenhüner
Published: (2020-10-01)

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
by: Lucas C Godoy, et al.
Published: (2019-12-01)

The Current Landscape of Donation After Circulatory Death Heart Transplantation—Where Do We Stand?
by: Albert Dweck, et al.
Published: (2025-04-01)

Integrating Body Schema and Body Image in Neurorehabilitation: Where Do We Stand and What’s Next?
by: Rocco Salvatore Calabrò
Published: (2025-04-01)

Where are We at and Where are We heading to?
by: Sergio Eduardo de Paiva Gonçalves
Published: (2014-09-01)